{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:15:01Z","timestamp":1792782901309,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Sichuan Science and Technology Program","award":["24NSFSC0358"],"award-info":[{"award-number":["24NSFSC0358"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10072-025-08361-x","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T03:37:48Z","timestamp":1752205068000},"page":"5123-5132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of creatinine level with neurodegenerative disorders: a prospective cohort study and Mendelian randomization analysis"],"prefix":"10.1007","volume":"46","author":[{"given":"Peixi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0947-1151","authenticated-orcid":false,"given":"Huifang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"issue":"4","key":"8361_CR1","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","volume":"186","author":"DM Wilson","year":"2023","unstructured":"Wilson DM 3rd, Cookson MR, Van Den Bosch L, Zetterberg H, Holtzman DM, Dewachter I (2023) Hallmarks of neurodegenerative diseases. Cell 186(4):693\u2013714","journal-title":"Cell"},{"issue":"10","key":"8361_CR2","doi-asserted-by":"publisher","first-page":"e551","DOI":"10.1016\/S2468-2667(20)30190-0","volume":"5","author":"G Deuschl","year":"2020","unstructured":"Deuschl G, Beghi E, Fazekas F, Varga T, Christoforidi KA, Sipido E, Bassetti CL, Vos T, Feigin VL (2020) The burden of neurological diseases in europe: an analysis for the global burden of disease study 2017. Lancet Public Health 5(10):e551\u2013e567","journal-title":"Lancet Public Health"},{"key":"8361_CR3","doi-asserted-by":"crossref","unstructured":"Kon\u00ed\u010dkov\u00e1 D, Men\u0161\u00edkov\u00e1 K, Tu\u010dkov\u00e1 L, H\u00e9nykov\u00e1 E, Strnad M, Friedeck\u00fd D, Stejskal D, Mat\u011bj R, Ka\u0148ovsk\u00fd P (2022) Biomarkers of neurodegenerative diseases: biology, taxonomy, clinical relevance, and current research status. Biomedicines 10(7)","DOI":"10.3390\/biomedicines10071760"},{"issue":"6","key":"8361_CR4","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","volume":"27","author":"O Hansson","year":"2021","unstructured":"Hansson O (2021) Biomarkers for neurodegenerative diseases. Nat Med 27(6):954\u2013963","journal-title":"Nat Med"},{"key":"8361_CR5","doi-asserted-by":"publisher","first-page":"103313","DOI":"10.1016\/j.ebiom.2021.103313","volume":"65","author":"Blood biomarkers of","year":"2021","unstructured":"Blood biomarkers of (2021) neurodegeneration-progress on non-invasive diagnostics. EBioMedicine 65:103313","journal-title":"EBioMedicine"},{"issue":"4","key":"8361_CR6","first-page":"172","volume":"101","author":"D Alcolea","year":"2023","unstructured":"Alcolea D, Beeri MS, Rojas JC, Gardner RC, Lle\u00f3 A (2023) Blood biomarkers in neurodegenerative diseases. Implications Clin Neurologist 101(4):172\u2013180","journal-title":"Implications Clin Neurologist"},{"issue":"3","key":"8361_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/00002093-200207000-00009","volume":"16","author":"Z Arvanitakis","year":"2002","unstructured":"Arvanitakis Z, Lucas JA, Younkin LH, Younkin SG, Graff-Radford NR (2002) Serum creatinine levels correlate with plasma amyloid Beta protein. Alzheimer Dis Assoc Disord 16(3):187\u2013190","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"2","key":"8361_CR8","doi-asserted-by":"publisher","first-page":"fcaa152","DOI":"10.1093\/braincomms\/fcaa152","volume":"2","author":"C Cui","year":"2020","unstructured":"Cui C, Sun J, Pawitan Y, Piehl F, Chen H, Ingre C, Wirdefeldt K, Evans M, Andersson J, Carrero JJ et al (2020) Creatinine and C-reactive protein in amyotrophic lateral sclerosis, multiple sclerosis and parkinson\u2019s disease. Brain Commun 2(2):fcaa152","journal-title":"Brain Commun"},{"issue":"7\u20138","key":"8361_CR9","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1080\/21678421.2020.1774610","volume":"21","author":"J Liu","year":"2020","unstructured":"Liu J, Luo X, Chen X, Shang H (2020) Serum creatinine levels in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis. Amyotroph Lateral Scler Frontotemporal Degeneration 21(7\u20138):502\u2013508","journal-title":"Amyotroph Lateral Scler Frontotemporal Degeneration"},{"issue":"11","key":"8361_CR10","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1212\/01.WNL.0000036618.68674.7A","volume":"59","author":"PA Calabresi","year":"2002","unstructured":"Calabresi PA, Austin H, Racke MK, Goodman A, Choyke P, Maloni H, McFarland HF (2002) Impaired renal function in progressive multiple sclerosis. Neurology 59(11):1799\u20131801","journal-title":"Neurology"},{"issue":"6","key":"8361_CR11","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/ageing\/afp137","volume":"38","author":"S Abou-Raya","year":"2009","unstructured":"Abou-Raya S, Helmii M, Abou-Raya A (2009) Bone and mineral metabolism in older adults with parkinson\u2019s disease. Age Ageing 38(6):675\u2013680","journal-title":"Age Ageing"},{"issue":"12","key":"8361_CR12","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1007\/s10072-017-3138-8","volume":"38","author":"J Mandrioli","year":"2017","unstructured":"Mandrioli J, Rosi E, Fini N, Fasano A, Raggi S, Fantuzzi AL, Bedogni G (2017) Changes in routine laboratory tests and survival in amyotrophic lateral sclerosis. Neurol Sci 38(12):2177\u20132182","journal-title":"Neurol Sci"},{"issue":"3","key":"8361_CR13","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, Downey P, Elliott P, Green J, Landray M et al (2015) UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 12(3):e1001779","journal-title":"PLoS Med"},{"issue":"2","key":"8361_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41588-020-00757-z","volume":"53","author":"N Sinnott-Armstrong","year":"2021","unstructured":"Sinnott-Armstrong N, Tanigawa Y, Amar D, Mars N, Benner C, Aguirre M, Venkataraman GR, Wainberg M, Ollila HM, Kiiskinen T et al (2021) Genetics of 35 blood and urine biomarkers in the UK biobank. Nat Genet 53(2):185\u2013194","journal-title":"Nat Genet"},{"issue":"1","key":"8361_CR15","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41398-022-02052-3","volume":"12","author":"C Li","year":"2022","unstructured":"Li C, Liu J, Lin J, Shang H (2022) COVID-19 and risk of neurodegenerative disorders: A Mendelian randomization study. Transl Psychiatry 12(1):283","journal-title":"Transl Psychiatry"},{"issue":"1","key":"8361_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s13539-012-0079-1","volume":"4","author":"SS Patel","year":"2013","unstructured":"Patel SS, Molnar MZ, Tayek JA, Ix JH, Noori N, Benner D, Heymsfield S, Kopple JD, Kovesdy CP, Kalantar-Zadeh K (2013) Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature. J cachexia Sarcopenia Muscle 4(1):19\u201329","journal-title":"J cachexia Sarcopenia Muscle"},{"issue":"3\u20134","key":"8361_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/21678421.2019.1572192","volume":"20","author":"D Lanznaster","year":"2019","unstructured":"Lanznaster D, Bejan-Angoulvant T, Patin F, Andres CR, Vourc\u2019h P, Corcia P, Blasco H (2019) Plasma creatinine and amyotrophic lateral sclerosis prognosis: a systematic review and meta-analysis. Amyotroph Lateral Scler Frontotemporal Degeneration 20(3\u20134):199\u2013206","journal-title":"Amyotroph Lateral Scler Frontotemporal Degeneration"},{"key":"8361_CR18","doi-asserted-by":"crossref","unstructured":"Cui C, Sun J, Pawitan Y, Piehl F, Chen H, Ingre C, Wirdefeldt K, Evans M, Andersson J, Carrero J-J et al (2020) Creatinine and C-reactive protein in amyotrophic lateral sclerosis, multiple sclerosis and parkinson\u2019s disease. Brain Commun 2(2)","DOI":"10.1093\/braincomms\/fcaa152"},{"issue":"9","key":"8361_CR19","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1001\/jamaneurol.2014.1129","volume":"71","author":"A Chi\u00f2","year":"2014","unstructured":"Chi\u00f2 A, Calvo A, Bovio G, Canosa A, Bertuzzo D, Galmozzi F, Cugnasco P, Clerico M, De Mercanti S, Bersano E et al (2014) Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: A Population-Based study. JAMA Neurol 71(9):1134\u20131142","journal-title":"JAMA Neurol"},{"issue":"2","key":"8361_CR20","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/acn3.51299","volume":"8","author":"QF Guo","year":"2021","unstructured":"Guo QF, Hu W, Xu LQ, Luo H, Wang N, Zhang QJ (2021) Decreased serum creatinine levels predict short survival in amyotrophic lateral sclerosis. Ann Clin Transl Neurol 8(2):448\u2013455","journal-title":"Ann Clin Transl Neurol"},{"issue":"Pt 9","key":"8361_CR21","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1093\/brain\/aws170","volume":"135","author":"A Hashizume","year":"2012","unstructured":"Hashizume A, Katsuno M, Banno H, Suzuki K, Suga N, Mano T, Atsuta N, Oe H, Watanabe H, Tanaka F et al (2012) Longitudinal changes of outcome measures in spinal and bulbar muscular atrophy. Brain 135(Pt 9):2838\u20132848","journal-title":"Brain"},{"issue":"5","key":"8361_CR22","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s00726-011-0850-1","volume":"40","author":"T Klopstock","year":"2011","unstructured":"Klopstock T, Elstner M, Bender A (2011) Creatine in mouse models of neurodegeneration and aging. Amino Acids 40(5):1297\u20131303","journal-title":"Amino Acids"},{"issue":"5","key":"8361_CR23","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/mus.20489","volume":"33","author":"I Hervias","year":"2006","unstructured":"Hervias I, Beal MF, Manfredi G (2006) Mitochondrial dysfunction and amyotrophic lateral sclerosis. Muscle Nerve 33(5):598\u2013608","journal-title":"Muscle Nerve"},{"issue":"3","key":"8361_CR24","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1046\/j.1471-4159.2003.02160.x","volume":"88","author":"P Klivenyi","year":"2004","unstructured":"Klivenyi P, Kiaei M, Gardian G, Calingasan NY, Beal MF (2004) Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a Transgenic mouse model of amyotrophic lateral sclerosis. J Neurochem 88(3):576\u2013582","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"8361_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0022-510X(01)00611-6","volume":"191","author":"L Mazzini","year":"2001","unstructured":"Mazzini L, Balzarini C, Colombo R, Mora G, Pastore I, De Ambrogio R, Caligari M (2001) Effects of creatine supplementation on exercise performance and muscular strength in amyotrophic lateral sclerosis: preliminary results. J Neurol Sci 191(1\u20132):139\u2013144","journal-title":"J Neurol Sci"},{"issue":"9","key":"8361_CR26","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1212\/01.WNL.0000142992.81995.F0","volume":"63","author":"JM Shefner","year":"2004","unstructured":"Shefner JM, Cudkowicz ME, Schoenfeld D, Conrad T, Taft J, Chilton M, Urbinelli L, Qureshi M, Zhang H, Pestronk A et al (2004) A clinical trial of creatine in ALS. Neurology 63(9):1656\u20131661","journal-title":"Neurology"},{"issue":"4","key":"8361_CR27","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1002\/ana.10554","volume":"53","author":"GJ Groeneveld","year":"2003","unstructured":"Groeneveld GJ, Veldink JH, van der Tweel I, Kalmijn S, Beijer C, de Visser M, Wokke JH, Franssen H, van den Berg LH (2003) A randomized sequential trial of creatine in amyotrophic lateral sclerosis. Ann Neurol 53(4):437\u2013445","journal-title":"Ann Neurol"},{"issue":"3","key":"8361_CR28","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/6568","volume":"5","author":"P Klivenyi","year":"1999","unstructured":"Klivenyi P, Ferrante RJ, Matthews RT, Bogdanov MB, Klein AM, Andreassen OA, Mueller G, Wermer M, Kaddurah-Daouk R, Beal MF (1999) Neuroprotective effects of creatine in a Transgenic animal model of amyotrophic lateral sclerosis. Nat Med 5(3):347\u2013350","journal-title":"Nat Med"},{"issue":"5","key":"8361_CR29","doi-asserted-by":"publisher","first-page":"e37258","DOI":"10.1371\/journal.pone.0037258","volume":"7","author":"YE Yoo","year":"2012","unstructured":"Yoo YE, Ko CP (2012) Dihydrotestosterone ameliorates degeneration in muscle, axons and motoneurons and improves motor function in amyotrophic lateral sclerosis model mice. PLoS ONE 7(5):e37258","journal-title":"PLoS ONE"},{"issue":"1","key":"8361_CR30","doi-asserted-by":"publisher","first-page":"28289","DOI":"10.1038\/s41598-024-79910-1","volume":"14","author":"Z Wang","year":"2024","unstructured":"Wang Z, Cao W, Deng B, Fan D (2024) Lower creatinine-to-cystatin c ratio associated with increased risk of incident amyotrophic lateral sclerosis in the prospective UK biobank cohort. Sci Rep 14(1):28289","journal-title":"Sci Rep"},{"key":"8361_CR31","doi-asserted-by":"crossref","unstructured":"Chen X-P, Wei Q-Q, Ou R-W, Hou Y-B, Zhang L-Y, Yuan X-Q, Yao Y-Q, Jia D-S, Zhang Q, Li W-X et al (2021) Creatine kinase in the diagnosis and prognostic prediction of amyotrophic lateral sclerosis: a retrospective case-control study. Neural Regeneration Res 16(3)","DOI":"10.4103\/1673-5374.293159"},{"key":"8361_CR32","doi-asserted-by":"crossref","unstructured":"Snow WM, Cadonic C, Cortes-Perez C, Adlimoghaddam A, Roy Chowdhury SK, Thomson E, Anozie A, Bernstein MJ, Gough K, Fernyhough P et al (2020) Sex-Specific Effects of Chronic Creatine Supplementation on Hippocampal-Mediated Spatial Cognition in the 3xTg Mouse Model of Alzheimer\u2019s Disease. Nutrients 12(11)","DOI":"10.3390\/nu12113589"},{"key":"8361_CR33","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pbb.2014.12.014","volume":"130","author":"PJ Allen","year":"2015","unstructured":"Allen PJ, DeBold JF, Rios M, Kanarek RB (2015) Chronic high-dose creatine has opposing effects on depression-related gene expression and behavior in intact and sex hormone-treated gonadectomized male and female rats. Pharmacol Biochem Behav 130:22\u201333","journal-title":"Pharmacol Biochem Behav"},{"issue":"5\u20136","key":"8361_CR34","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/17482960802566824","volume":"10","author":"A Chi\u00f2","year":"2009","unstructured":"Chi\u00f2 A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, Traynor BG (2009) Prognostic factors in ALS: A critical review. Amyotroph Lateral Sclerosis: Official Publication World Federation Neurol Res Group Motor Neuron Dis 10(5\u20136):310\u2013323","journal-title":"Amyotroph Lateral Sclerosis: Official Publication World Federation Neurol Res Group Motor Neuron Dis"},{"issue":"1","key":"8361_CR35","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1515\/jomb-2016-0028","volume":"36","author":"Z Erbayraktar","year":"2017","unstructured":"Erbayraktar Z, Turan Evlice A, Yilmaz G, Yazici C, Yener G, Ulusu NN (2017) Evaluation of renal function in alzheimer\u2019s disease and geriatric patients: results from a Turkish Two-center study. J Med Biochem 36(1):54\u201361","journal-title":"J Med Biochem"},{"issue":"11","key":"8361_CR36","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.3390\/nu12113589","volume":"12","author":"WM Snow","year":"2020","unstructured":"Snow WM, Cadonic C, Cortes-Perez C, Adlimoghaddam A, Roy Chowdhury SK, Thomson E, Anozie A, Bernstein MJ, Gough K, Fernyhough P et al (2020) Sex-Specific effects of chronic creatine supplementation on Hippocampal-Mediated Spatial cognition in the 3xTg mouse model of alzheimer\u2019s disease. Nutrients 12(11):3589","journal-title":"Nutrients"},{"issue":"6","key":"8361_CR37","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1001\/jama.2015.120","volume":"313","author":"K Kieburtz","year":"2015","unstructured":"Kieburtz K, Tilley BC, Elm JJ, Babcock D, Hauser R, Ross GW, Augustine AH, Augustine EU, Aminoff MJ, Bodis-Wollner IG et al (2015) Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial. JAMA 313(6):584\u2013593","journal-title":"JAMA"},{"issue":"1","key":"8361_CR38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/19390210802328974","volume":"5","author":"SK Malin","year":"2008","unstructured":"Malin SK, Cotugna N, Fang CS (2008) Effect of creatine supplementation on muscle capacity in individuals with multiple sclerosis. J Diet Supplements 5(1):20\u201332","journal-title":"J Diet Supplements"},{"issue":"12","key":"8361_CR39","first-page":"Cd005225","volume":"12","author":"DM Pastula","year":"2012","unstructured":"Pastula DM, Moore DH, Bedlack RS (2012) Creatine for amyotrophic lateral sclerosis\/motor neuron disease. Cochrane Database Syst Rev 12(12):Cd005225","journal-title":"Cochrane Database Syst Rev"},{"key":"8361_CR40","doi-asserted-by":"crossref","unstructured":"Jan Groeneveld G, Veldink JH, van der Tweel I, Kalmijn S, Beijer C, de Visser M, Wokke JHJ, Franssen H (2003) Berg lhvd: A randomized sequential trial of creatine in amyotrophic lateral sclerosis. 53(4):437\u2013445","DOI":"10.1002\/ana.10554"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08361-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08361-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08361-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T03:14:59Z","timestamp":1759288499000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08361-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["8361"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08361-x","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]},"assertion":[{"value":"25 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by West China Hospital, Sichuan University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}